← FDA Drug Approvals (Drugs@FDA)

NIPENT

NDA · New Drug Application · Sponsor: HOSPIRA INC · Approved 1991-10-11

Drug application

FDA Application #
NDA020122
Application type
New Drug Application
Brand name
NIPENT
Generic name
PENTOSTATIN
Active ingredients
PENTOSTATIN
Dosage form
INJECTABLE
Route
INJECTION
Marketing status
Prescription
Sponsor
HOSPIRA INC
Manufacturer
Hospira, Inc.
First approval
1991-10-11

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown